PTPRC and neoplasm: To investigate the role of the tumor and stromal compartment in regulating ICT resistance, we first conducted scRNAseq on CD45-negative cells sorted from orthotopic B16F10 and mT4 tumors (Fig. 1a, Supplementary Fig. 1c, Supplementary Data 1).